We are live on ! Find out more
ORIA

Orion Biotech Opportunities Corp. Class A Ordinary Share
ORIA

Delisted

ORIA was delisted on the 28th of April, 2023.

Back to rankings

Fund managers haven’t disclosed any holdings of ORIA yet.

ORIA Hedge Fund Activity: Q2 2023 in Review

0 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Orion Biotech Opportunities Corp. Class A Ordinary Share (ORIA) for Q2 2023, worth a combined $0 — down 100% from $145M a quarter earlier.

Sellers outnumbered buyers: 49 funds closed out of ORIA and 0 opened new positions — a net loss of 49 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Aristeia Capital, exiting entirely with an estimated $13.4M sold.

  • 0 institutional investors held Orion Biotech Opportunities Corp. Class A Ordinary Share (ORIA) as of Q2 2023, down from 49 in Q1 2023.
  • Funds reported $0 of Orion Biotech Opportunities Corp. Class A Ordinary Share stock for Q2 2023, down 100% quarter-over-quarter.
  • 0 funds opened new Orion Biotech Opportunities Corp. Class A Ordinary Share positions in Q2 2023 and 49 closed out, a net change of -49 holders.
  • The largest Orion Biotech Opportunities Corp. Class A Ordinary Share seller in Q2 2023 was Aristeia Capital, an estimated $13.4M sold.

Based on aggregated 13F filings for Q2 2023.